Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients

Clinical Cancer Research

Volumn 8, Issue 6, 2002, Pages 1843-1848

  Volm, Manfred ^a   Koomägi, Reet ^a   Mattern, Jürgen ^a   Efferth, Thomas ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLINE; FAS ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN C JUN; PROTEIN FOS; PROTEIN P53; RAS PROTEIN;

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

CARCINOMA, NON-SMALL-CELL LUNG; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM PROTEINS; SURVIVAL RATE; TIME FACTORS;

EID: 0036278826     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Non-small cell lung cancer
2. Mutation of cell cycle regulators. Biological and clinical implications of human neoplasia
3. Apoptosis in the pathogenesis and treatment of disease
4. Expression of Fas (CD95/APO-I) and Fas ligand in lung cancer, its prognostic and predictive relevance
5. Clinical applications of research on angiogenesis
6. The role of ras and myc oncogenes in human solid turnouts and their relevance in diagnosis and prognosis
7. Oncoprotein (c-myc, c-erbb1, c-erbb2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations
8. Prognostic value of ERBB1, VEGF, cyclin A, FOS, JUN, and MYC in patients with squamous cell lung carcinomas
9. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia
10. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer
11. Analysis of long-term survival in patients with locally advances non-small cell lung cancer
12. Characteristics of 49 patients who survived for 5 years following radical radiation therapy for non-small cell lung cancer: The potential for cure
13. Cluster analysis and display of genome-wide expression pattern
14. A gene expression database for the molecular pharmacology of cancer
15. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen
16. Prognostic factors in small-cell carcinoma of the lung: An analysis of 1,521 patients
17. Cancer classification with DNA microarrays. Is less more?